← Back to Search

Mechanical Ventilation

NAVA vs. CMV for Severe Bronchopulmonary Dysplasia

N/A
Recruiting
Led By Erik Jensen, MD, MSCE
Research Sponsored by Children's Hospital of Philadelphia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Receiving invasive mechanical ventilation for ongoing lung disease
Severe BPD [as per National Institutes of Health (NIH) consensus definition] diagnosed at 36 weeks postmenstrual age
Must not have
Acute respiratory instability defined as a ventilator rate increase > 15 beats per minute (bpm), Positive end-expiratory pressure (PEEP) increase > 2 cm/water (H2O), sustained FiO2 increase > 20%, and/or prescribed increase in tidal volume > 2 mL/kg within 24 hours prior to enrollment will be excluded.
Current treatment with high frequency mechanical ventilation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 days per study arm
Awards & highlights

Summary

This trial will compare two modes of mechanical ventilation - conventional and neurally adjusted ventilatory assist - for 20 infants with severe bronchopulmonary dysplasia.

Who is the study for?
This trial is for prematurely born infants and young children up to 2 years old with severe bronchopulmonary dysplasia (BPD). They must be on invasive mechanical ventilation, not expected to be extubated within 11 days of joining, and have parental consent. Infants with certain health conditions or recent treatments are excluded.
What is being tested?
The study compares two types of breathing support in severely ill babies: conventional mechanical ventilation (CMV) and neurally adjusted ventilatory assist (NAVA). It will look at lung function, oxygen exchange, and comfort levels during treatment in a small group of patients.
What are the potential side effects?
While the trial description does not specify side effects, both NAVA and CMV can potentially cause discomfort due to the artificial airway used for breathing support. There may also be risks associated with changes in respiratory settings.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am on a ventilator due to lung disease.
Select...
My baby was diagnosed with severe BPD at 36 weeks postmenstrual age.
Select...
I am between 36 weeks postmenstrual age and 2 years old.
Select...
My pregnancy is 32 weeks along or less.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I haven't needed significant changes to my breathing support settings in the last 24 hours.
Select...
I am currently on a high-frequency ventilator.
Select...
I have a known issue with my diaphragm.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 days per study arm
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 days per study arm for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Oxygen saturation (SpO2) index
Secondary study objectives
Sedation Medications
Stress

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Neurally Adjusted Ventilatory Assist (NAVA)Experimental Treatment1 Intervention
Subjects will be ventilated on neurally adjusted ventilatory assist (NAVA) mode with data collected for the 5 day time frame to compare with placebo arm
Group II: Conventional Flow Triggered Mechanical Ventilation (CMV)Placebo Group1 Intervention
Subjects will be ventilated with conventional mechanical ventilation with data collected for the 5 day time frame to compare to the experimental arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
NAVA
2013
N/A
~220

Find a Location

Who is running the clinical trial?

Children's Hospital of PhiladelphiaLead Sponsor
721 Previous Clinical Trials
8,604,302 Total Patients Enrolled
9 Trials studying Bronchopulmonary Dysplasia
614 Patients Enrolled for Bronchopulmonary Dysplasia
American Respiratory Care FoundationUNKNOWN
Children's Miracle NetworkOTHER
22 Previous Clinical Trials
1,764 Total Patients Enrolled

Media Library

CMV (Mechanical Ventilation) Clinical Trial Eligibility Overview. Trial Name: NCT04821453 — N/A
Bronchopulmonary Dysplasia Research Study Groups: Neurally Adjusted Ventilatory Assist (NAVA), Conventional Flow Triggered Mechanical Ventilation (CMV)
Bronchopulmonary Dysplasia Clinical Trial 2023: CMV Highlights & Side Effects. Trial Name: NCT04821453 — N/A
CMV (Mechanical Ventilation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04821453 — N/A
~6 spots leftby Oct 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top